- 专利标题: B7-H4 ANTIBODIES AND METHODS OF USE THEREOF
-
申请号: US16814627申请日: 2020-03-10
-
公开(公告)号: US20200255528A1公开(公告)日: 2020-08-13
- 发明人: Charles KAPLAN , Derrick HOUSER , Luis BORGES , Gloria BRATTICH , David BELLOVIN , Felicia KEMP , Majid GHODDUSI , Nels P. NIELSON , Kathy MILLER , Maike SCHMIDT
- 申请人: Five Prime Therapeutics, Inc.
- 申请人地址: US CA South San Francisco
- 专利权人: Five Prime Therapeutics, Inc.
- 当前专利权人: Five Prime Therapeutics, Inc.
- 当前专利权人地址: US CA South San Francisco
- 主分类号: C07K16/28
- IPC分类号: C07K16/28 ; G01N33/574 ; A61P35/00
摘要:
The present disclosure provides antibodies and antigen-binding fragments thereof that specifically bind to human B7-H4 (and optionally cynomolgus monkey, mouse, and/or rat B7-H4) and compositions comprising such antibodies or antigen-binding fragments thereof. In a specific aspect, the antibodies or antigen-binding fragments thereof that specifically bind to human B7-H4 increase T cell proliferation, increase interferon-gamma production, and/or deplete B7-H4 expressing cells via ADCC activity. The present disclosure also provides methods for treating disorders, such as cancer, by administering an antibody or antigen-binding fragment thereof that specifically binds to human B7-H4.
公开/授权文献
- US11814431B2 B7-H4 antibodies and methods of use thereof 公开/授权日:2023-11-14
信息查询